A detailed history of Ggm Financials LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ggm Financials LLC holds 4,604 shares of ABT stock, worth $543,870. This represents 0.45% of its overall portfolio holdings.

Number of Shares
4,604
Previous 4,581 0.5%
Holding current value
$543,870
Previous $476 Million 10.27%
% of portfolio
0.45%
Previous 0.44%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$100.07 - $118.13 $2,301 - $2,716
23 Added 0.5%
4,604 $525 Million
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $461,444 - $515,087
4,581 New
4,581 $476 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ggm Financials LLC Portfolio

Follow Ggm Financials LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ggm Financials LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ggm Financials LLC with notifications on news.